Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Avid Bioservices Inc (CDMOP)

Avid Bioservices Inc (CDMOP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 149,266 K
  • Annual Income, $ 560 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade CDMOP with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.01 +0.20%
on 03/30/21
25.50 -1.72%
on 03/23/21
-0.21 (-0.83%)
since 03/12/21
3-Month
25.01 +0.20%
on 03/30/21
31.95 -21.56%
on 03/04/21
-4.43 (-15.02%)
since 01/12/21
52-Week
21.00 +19.33%
on 04/20/20
31.95 -21.56%
on 03/04/21
+3.06 (+13.91%)
since 04/09/20

Most Recent Stories

More News
Avid Bioservices to Join S&P SmallCap 600 Index

TUSTIN, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing...

CDMOP : 25.06 (unch)
CDMO : 8.67 (+6.51%)
Avid Bioservices Announces Expansion into Viral Vector Development and Manufacturing Services for Cell and Gene Therapy

Leverages Established Track Record of Excellence in Biologics CGMP Manufacturing to Address the Rapidly Growing Cell and Gene Therapy Market World-Class...

CDMO : 8.67 (+6.51%)
CDMOP : 25.06 (unch)
Avid Bioservices Appoints Matthew Kwietniak as Chief Commercial Officer

Accomplished Senior Executive with Nearly 30 Years of Sales Experience Spanning CDMO Offerings, Clinical Development Services and Scientific Products...

CDMO : 8.67 (+6.51%)
CDMOP : 25.06 (unch)
Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2021 and Recent Developments

-- Recorded First Quarter Revenue of $30.8 Million --

CDMOP : 25.06 (unch)
CDMO : 8.67 (+6.51%)
Avid Bioservices to Participate at Upcoming Investor Conferences

TUSTIN, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives...

CDMOP : 25.06 (unch)
CDMO : 8.67 (+6.51%)
Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2022 After Market Close on September 8, 2021

TUSTIN, Calif., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives...

CDMOP : 25.06 (unch)
CDMO : 8.67 (+6.51%)
Avid Bioservices Announces Appointment of Esther M. Alegria, Ph.D., to Board of Directors

Former SVP of Global Manufacturing at Biogen Has Nearly 30 Years of Biopharmaceutical Industry Experience

CDMOP : 25.06 (unch)
CDMO : 8.67 (+6.51%)
Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2021 and Recent Developments

-- Recorded Fourth Quarter Revenue of $27.6 Million and Annual Revenue of $95.9 Million --

CDMOP : 25.06 (unch)
CDMO : 8.67 (+6.51%)
Avid Bioservices to Report Financial Results For Quarter and Fiscal Year Ended April 30, 2021 After Market Close on June 29, 2021

TUSTIN, Calif., June 22, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives...

CDMOP : 25.06 (unch)
CDMO : 8.67 (+6.51%)
Avid Bioservices to Serve as Commercial Manufacturer for ADC Therapeutics’ ZYNLONTA™ (Loncastuximab Tesirine-Lpyl)

ZYNLONTAâ„¢ Recently Approved as First and Only CD19-Targeted Antibody Drug Conjugate for Single-Agent Treatment for Adult Patients with Relapsed or Refractory (r/r) Diffuse Large B-cell Lymphoma (DLBCL)...

CDMO : 8.67 (+6.51%)
CDMOP : 25.06 (unch)
ADCT : 4.30 (-5.91%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Key Turning Points

3rd Resistance Point 25.10
2nd Resistance Point 25.09
1st Resistance Point 25.07
Last Price 25.06
1st Support Level 25.04
2nd Support Level 25.03
3rd Support Level 25.01

See More

52-Week High 31.95
Fibonacci 61.8% 27.77
Fibonacci 50% 26.48
Fibonacci 38.2% 25.18
Last Price 25.06
52-Week Low 21.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar